Q Fever Market: Current Analysis and Forecast (2022-2028)
Emphasis on Type (Acute Q Fever, Chronic Q Fever), Medication Type (Antibiotics, Antimalarial and Corticosteroids), End-Users (Hospitals, clinics and research institutes) and Region/Country.
The Q Fever Market was valued at USD 4260 Mn in 2021 and is expected to grow with CAGR of 5% during the forecast period (2022-2030). The Q fever infection mostly occurs in the month of April and May. Most Q fever infections occur in the spring and summer, especially in April and May. Additionally, the seasonal peak in infections coincides with the birthing season for carrier species: sheep, goats, and cows. This increase is related to the livestock management tasks associated with the birthing season. Further, Q fever is also more common among men and middle-aged or older adults. This is believed to be partially related to the risk in professions that involve substantial livestock management, such as ranching. Moreover, key risk factors associated with it also increase the likelihood of experiencing chronic Q fever. Specifically, individuals with cardiac abnormalities such as endocarditis or heart valve defects have a higher risk of chronic Q fever after an infection. Thus, these above-mentioned factors are anticipated to fuel the market growth in the forecasted period.
Some of the major players operating in the market include Sun Pharmaceutical Industries Ltd., Abbott., Aurobindo Pharma., Pfizer Inc., lupin, Bayers AG, Novartis Pharmaceutical Corporation, GSK plc., Merck & Co., Inc., Sanofi
Insights Presented in the Report
“Amongst type, the chronic Q Fever segment is growing with significant CAGR in 2021 market”
Based on type, the market is bifurcated into acute Q-Fever and Chronic Q-Fever. Amongst these, the chronic Q-Q-fever segment is anticipated to grow with a significant CAGR in the forecasted period. This is due to the raising awareness amongst the people of Q fever. Increasing awareness about the potential seriousness of chronic Q fever: As more people become aware of the potential seriousness of chronic Q fever, there is likely to be an increase in demand for diagnostic tests and treatments for the condition.
“Amongst medication types, the corticosteroid segment is growing with a significant CAGR in the market in 2021”
Based on the route of administration, the market is segmented into antibiotics, antimalarial and corticosteroids. Amongst these, the corticosteroid segment is anticipated to grow with a significant CAGR. Corticosteroids, such as prednisone, can be used to treat Q fever in some cases. They are often used in combination with other medications, such as antibiotics, to help reduce inflammation and prevent complications. Additionally, can help reduce fever, improve lung function, and reduce the risk of complications such as heart inflammation or kidney failure. These elements are driving the growth of market demand for Q fever market.
“Amongst end-users, the research institute segment is growing with a significant CAGR in the market in 2021”
Based on the end-users the market is segmented into hospitals, clinics and research institute. Amongst these, the research institute segment is anticipated to grow with a significant CAGR. This is attributed to the demand for novel and effective antibiotics increasing, and research institutes are at the forefront of developing new and improved Q-fever-based antibiotics. These new antibiotics are expected to have better efficacy and reduced side effects compared to existing ones, which is expected to drive the demand for Q fever-based antibiotics in the near future. Additionally, research institutes are also working on the development of new delivery systems for Q-fever-based antibiotics, which can improve their efficacy and reduce the risk of resistance. This research is expected to lead to the development of new and improved formulations of Q fever-based antibiotics, which will drive the growth of the market of home-healthcare facilities. Thus, these factors are anticipated to fuel the market growth for Q fever in the near future.
“North America is anticipated to grow with significant CAGR of the Q Fever market in 2021”
North America is anticipated to grow with a significant CAGR in the 2021 market. This is attributed towards the rising incidence of Q fever in this region. For instance, according to the Centre for Disease, 2019 report, about 5 out of 10 people living in the United States suffer from Q fever. Additionally, the availability of advanced medical equipment and the presence of key market players in this region is attributing to the market growth in this region. Fever Market. These above-mentioned factors are boosting the demand for the Q Fever Market.
Q fever Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global Q Fever Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Q Fever Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Q Fever Market were the three major steps undertaken to create and analyze the adoption of Q Fever in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Q Fever Market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Q Fever Market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Q Fever Market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, medication type and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Q Fever Market. Further, we conducted factor analysis using dependent and independent variables such as type, medication type and end-users of the Q fever market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Q Fever Market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Q Fever Market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Q Fever market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Q Fever Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Q-Fever Market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of disorder type, and service type in the global Q Fever Market.
The main objective of the Global Q Fever Market Study
The current & future market trends of the global Q Fever Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Q Fever Market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the types, types of medication and end-users
- Define and analysis of the regulatory framework for the Q Fever industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Q Fever market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Q Fever Market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
